These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. RYR2 and CASQ2 mutations in patients suffering from catecholaminergic polymorphic ventricular tachycardia. Lahat H; Pras E; Eldar M Circulation; 2003 Jan; 107(3):e29; author reply e29. PubMed ID: 12551888 [No Abstract] [Full Text] [Related]
75. The cardiac ryanodine receptor (RyR2) and its role in heart disease. Taur Y; Frishman WH Cardiol Rev; 2005; 13(3):142-6. PubMed ID: 15831148 [TBL] [Abstract][Full Text] [Related]
76. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973 [TBL] [Abstract][Full Text] [Related]
77. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2. Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169 [TBL] [Abstract][Full Text] [Related]
78. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535 [TBL] [Abstract][Full Text] [Related]
79. The phenotype of a CASQ2 mutation in a Saudi family with catecholaminergic polymorphic ventricular tachycardia. Al-Hassnan ZN; Tulbah S; Al-Manea W; Al-Fayyadh M Pacing Clin Electrophysiol; 2013 May; 36(5):e140-2. PubMed ID: 22650415 [TBL] [Abstract][Full Text] [Related]